Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Enanta Pharmaceuticals, Inc.
| Revenue | 67.6 M |
| Cost Of Revenue | 0 |
| Gross Profit | 67.6 M |
| Operating Expenses | 189 M |
| Operating Income | -122 M |
| Other Expenses | -5.65 M |
| Net Income | -116 M |
Income Statement
Millions
| Sep-2024 | Sep-2023 | Sep-2022 | Sep-2021 | Sep-2020 | Sep-2019 | Sep-2018 | Sep-2017 | Sep-2016 | Sep-2015 | Sep-2014 | Sep-2013 | Sep-2012 | Sep-2011 | Sep-2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||
| Revenue | 67.6 | 79.2 | 86.2 | 97.1 | 122.5 | 205.2 | 206.6 | 102.8 | 88.3 | 160.9 | 47.7 | 32.1 | 41.7 | 41.9 | 22.8 |
| GROSS PROFIT | |||||||||||||||
| Cost Of Revenue | 0 | 0 | 3.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 67.6 | 79.2 | 83.2 | 97.1 | 122.5 | 205.2 | 206.6 | 102.8 | 88.3 | 160.9 | 47.7 | 32.1 | 41.7 | 41.9 | 22.8 |
| OPERATING INCOME | |||||||||||||||
| Operating Expenses | 189.3 | 216.4 | 210.0 | 206.6 | 164.1 | 168.5 | 118.3 | 78.2 | 57.4 | 36.7 | 28.8 | 23.0 | 20.4 | 16.6 | 15.8 |
| Selling, General and Administrative Expenses | 57.9 | 52.9 | 45.5 | 32.5 | 27.4 | 26.2 | 23.4 | 20.7 | 17.0 | 13.5 | 10.0 | 6.2 | 5.3 | 5.0 | 6.1 |
| Research and Development Expenses | 131.5 | 163.5 | 164.5 | 174.1 | 136.8 | 142.2 | 94.9 | 57.5 | 40.5 | 23.2 | 18.7 | 16.8 | 15.1 | 11.5 | 9.7 |
| Operating Income | (121.7) | (137.2) | (123.8) | (109.6) | (41.6) | 36.7 | 88.3 | 24.6 | 30.8 | 124.1 | 19.0 | 9.0 | 21.3 | 25.3 | 6.9 |
| PRE-TAX INCOME | |||||||||||||||
| Interest Income Expense | 10.9 | 5.1 | 1.6 | 0 | 0 | 8.8 | 4.9 | 40 K | 45 K | 8 K | 18 K | 31 K | 0 | 3.2 | 0 |
| Total Other Income | 3.9 | 6.2 | 1.7 | 2.0 | 6.6 | 8.8 | 4.8 | 2.3 | 1.7 | 1.3 | 0.3 | 0.6 | 0.1 | (2.0) | 0.8 |
| Pre-Tax Income | (117.8) | (131.0) | (122.2) | (107.6) | (35.0) | 45.6 | 93.1 | 26.9 | 32.6 | 125.5 | 19.3 | 9.6 | 21.4 | 23.3 | 7.7 |
| NET INCOME | |||||||||||||||
| Tax Provision | (1.7) | 2.8 | (0.4) | (28.6) | 1.1 | (0.8) | 21.2 | 9.2 | 10.9 | 46.5 | (15.2) | (0.2) | 0 | 3.2 | (0.2) |
| Net Income | (116.0) | (133.8) | (121.8) | (79.0) | (36.2) | 46.4 | 72.0 | 17.7 | 21.7 | 79.0 | 34.4 | 9.6 | 21.4 | 23.3 | 7.9 |
| EPS | 5.48 | 6.38 | 5.91 | 3.92 | 1.81 | 2.37 | 3.48 | 0.93 | 1.14 | 4.23 | 1.88 | 0.67 | 1.18 | 1.35 | 0.0169 |